In this episode, I sit down with Tuan Cao, co-founder of Life AI.

Tuan and his team started by building a web 2 alternative to 23 and Me, focused on the Asian genome.

But with the key difference, they gave users full control over their data.

That was just the beginning of a long road to build one of the industry's leading decentralized science projects.

Long before decI was even a term, Life AI has been building a decentralized foundation for genetics-based medicine and research.

Today, Life AI has established itself as a baseler protocol that traditional healthcare players are building on top of cheaply and quickly.

The future of genetic-based personalized treatments might have crypto underneath the hood.

Let's get into it.

Connect with the guest

Life AI ⁠https://www.lifenetwork.ai/en

Follow Life AI on Twitter/X ⁠https://x.com/lifenetwork_ai

Disclaimer

Ben Jacobs is a partner at Scenius Capital Management. All views expressed by Ben and the guests of this podcast are solely their opinions and do not reflect the opinions of Scenius Capital Management. Guests and the host may maintain positions in the assets or funds discussed in this podcast. You should not treat any opinion expressed by anyone on this podcast as a specific inducement to make a particular investment or follow a particular strategy but only as an expression of their personal opinion. This podcast is for informational purposes only.

The Use-Case: Life AI - Tuan Cao (Episode #54

Scenius Studio

The Use-Case: Life AI - Tuan Cao (Episode #54